Structural elucidation of metabolites of ritonavir and indinavir by liquid chromatography–mass spectrometry
- 1 October 2002
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 974 (1-2) , 91-101
- https://doi.org/10.1016/s0021-9673(02)01243-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mass spectrometrically detected directly coupled high performance liquid chromatography/nuclear magnetic resonance spectroscopy/mass spectrometry for the identification of xenobiotic metabolites in maize plantsRapid Communications in Mass Spectrometry, 2000
- Determination of Opiates and Cocaine and Its Metabolites in Biological Fluids by High-Performance Liquid Chromatography with Electrospray Tandem Mass SpectrometryJournal of Analytical Toxicology, 1999
- Identification of in vitro metabolites of indinavir by “intelligent automated LC-MS/MS” (INTAMS) utilizing triple quadrupole tandem mass spectrometryJournal of the American Society for Mass Spectrometry, 1999
- Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography/ tandem mass spectrometryRapid Communications in Mass Spectrometry, 1998
- Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavirBritish Journal of Clinical Pharmacology, 1997
- Metabolism of rifabutin in human enterocyte and liver microsomes: Kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents*Clinical Pharmacology & Therapeutics, 1997
- High-performance liquid chromatographic method for the determination of an HIV-1 non-nucleoside reverse transcriptase inhibitor (L-696,229) in plasma samples from animalsJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Current Knowledge and Future Prospects for the Use of HIV Protease InhibitorsDrugs, 1996
- Ion trap mass spectrometry of externally generated ionsAnalytical Chemistry, 1994
- Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.Proceedings of the National Academy of Sciences, 1991